Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
2.
J Racial Ethn Health Disparities ; 10(4): 2039-2053, 2023 08.
Article in English | MEDLINE | ID: mdl-36068482

ABSTRACT

The heroin epidemic has existed for decades, but a sharp rise in opioid overdose deaths (OODs) jolted the nation in the mid-twenty-teens and continues as a major health crisis to this day. Although the new wave of OODs was initially approached as a rural problem impacting a White/Caucasian demographic, surveillance records suggest severe impacts on African Americans and urban-dwelling individuals, which have been largely underreported. The focus of this report is on specific trends in OOD rates in Black and White residents in states with a significant Black urban population and declared as hotspots for OOD: (Maryland (MD), Illinois (IL), Michigan (MI), and Pennsylvania (PA)), and Washington District of Columbia (DC). We compare OODs by type of opioid, across ethnicities, across city/rural demographics, and to homicide rates using 2013-2020 data acquired from official Chief Medical Examiners' or Departments of Health (DOH) reports. With 2013 or 2014 as baseline, the OOD rate in major cities (Baltimore, Chicago, Detroit, Philadelphia) were elevated two-fold over all other regions of their respective state. In DC, Wards 7 and 8 OODs were consistently greater than other jurisdictions, until 2020 when the rate of change of OODs increased for the entire city. Ethnicity-wise, Black OOD rates exceeded White rates by four- to six-fold, with fentanyl and heroin having a disproportionate impact on Black opioid deaths. This disparity was aggravated by its intersection with the COVID-19 pandemic in 2020. African Americans and America's urban dwellers are vulnerable populations in need of social and political resources to address the ongoing opioid epidemic in under-resourced communities.


Subject(s)
Black or African American , Healthcare Disparities , Opiate Overdose , Opioid Epidemic , Social Determinants of Health , Urban Population , Adolescent , Humans , Analgesics, Opioid/adverse effects , Black or African American/statistics & numerical data , COVID-19/epidemiology , COVID-19/ethnology , Heroin/poisoning , Opioid Epidemic/statistics & numerical data , Opioid Epidemic/trends , Pandemics , Philadelphia/epidemiology , United States/epidemiology , Urban Population/statistics & numerical data , White/statistics & numerical data , Opiate Overdose/epidemiology , Opiate Overdose/ethnology , Opiate Overdose/mortality , Social Determinants of Health/ethnology , Social Determinants of Health/statistics & numerical data , Social Determinants of Health/trends , Healthcare Disparities/ethnology , Healthcare Disparities/statistics & numerical data , Healthcare Disparities/trends , Health Status Disparities
3.
J Biomed Inform ; 44(1): 75-9, 2011 Feb.
Article in English | MEDLINE | ID: mdl-20123131

ABSTRACT

The Cell Ontology (CL) aims for the representation of in vivo and in vitro cell types from all of biology. The CL is a candidate reference ontology of the OBO Foundry and requires extensive revision to bring it up to current standards for biomedical ontologies, both in its structure and its coverage of various subfields of biology. We have now addressed the specific content of one area of the CL, the section of the ontology dealing with hematopoietic cells. This section has been extensively revised to improve its content and eliminate multiple inheritance in the asserted hierarchy, and the groundwork has been laid for structuring the hematopoietic cell type terms as cross-products incorporating logical definitions built from relationships to external ontologies, such as the Protein Ontology and the Gene Ontology. The methods and improvements to the CL in this area represent a paradigm for improvement of the entire ontology over time.


Subject(s)
Blood Cells/cytology , Hematopoiesis , Medical Informatics , Vocabulary, Controlled , Animals , Humans
4.
Int Immunopharmacol ; 3(3): 403-15, 2003 Mar.
Article in English | MEDLINE | ID: mdl-12639818

ABSTRACT

Gallium arsenide (GaAs) is utilized in industries for its semiconductor and optical properties. Chemical exposure of animals systemically suppresses several immune functions. The ability of splenic B cells to activate antigen-specific helper CD4(+) T cell hybridomas was assessed, and various aspects of antigen-presenting cell function were examined. GaAs-exposed murine B cells were impaired in processing intact soluble protein antigens, and the defect was antigen dependent. In contrast, B cells after exposure competently presented peptides to the T cells, which do not require processing. Cell surface expression of major histocompatibility complex (MHC) class II molecules and several costimulatory molecules on splenic B cells, which are critical for helper T cell activation, was not affected by chemical exposure. GaAs exposure also did not influence the stability of MHC class II heterodimers, suggesting that the defect may precede peptide exchange. GaAs-exposed B cells contained a normal level of aspartyl cathepsin activity; however, proteolytic activities of thiol cathepsins B and L were approximately half the control levels. Furthermore, two cleavage fragments of invariant chain, a molecular chaperone of MHC class II molecules, were increased in GaAs-exposed B cells, indicative of defective degradation. Thus, diminished thiol proteolytic activity in B cells may be responsible for their impaired antigen processing and invariant chain degradation, which may contribute to systemic immunosuppression caused by GaAs exposure.


Subject(s)
Antigen-Presenting Cells/drug effects , B-Lymphocytes/drug effects , Gallium/toxicity , Immunity, Cellular/drug effects , Spleen/cytology , Animals , Antibodies, Monoclonal/pharmacology , Antigen Presentation/drug effects , Antigen-Presenting Cells/immunology , Antigens/immunology , Arsenicals , B-Lymphocytes/immunology , Blotting, Western , Cathepsins/biosynthesis , Cathepsins/metabolism , Cell Line , Electrophoresis, Polyacrylamide Gel , Endopeptidases/metabolism , Fluorescent Antibody Technique , Gene Expression Regulation/drug effects , Genes, MHC Class II/genetics , Mice , Spleen/drug effects , Spleen/immunology
5.
J Immunol ; 170(2): 905-12, 2003 Jan 15.
Article in English | MEDLINE | ID: mdl-12517956

ABSTRACT

The Ag-specific B cell receptor (BCR) expressed by B lymphocytes has two distinct functions upon interaction with cognate Ag: signal transduction (generation of intracellular second messenger molecules) and Ag internalization for subsequent processing and presentation. While it is known that plasma membrane domains, termed lipid rafts, are involved in BCR-mediated signal transduction, the precise role of plasma membrane lipid rafts in BCR-mediated Ag internalization and intracellular trafficking is presently unclear. Using a highly characterized model system, it was determined that while plasma membrane lipid rafts can be internalized by B lymphocytes, lipid rafts do not represent a major pathway for the rapid and efficient internalization of cell surface Ag-BCR complexes. Moreover, internalized plasma membrane lipid rafts are delivered to intracellular compartments distinct from those to which the bulk of internalized Ag-BCR complexes are delivered. These results demonstrate that B lymphocytes, like other cell types, possess at least two distinct endocytic pathways (i.e., clathrin-coated pits and plasma membrane lipid rafts) that deliver internalized ligands to distinct intracellular compartments. Furthermore, Ag-BCR complexes differentially access these two distinct internalization pathways.


Subject(s)
Antigens/metabolism , Endocytosis/immunology , Intracellular Fluid/immunology , Intracellular Fluid/metabolism , Membrane Microdomains/physiology , Receptors, Antigen, B-Cell/physiology , Animals , B-Lymphocytes/immunology , B-Lymphocytes/metabolism , Cholera Toxin/immunology , Cholera Toxin/metabolism , Horseradish Peroxidase/metabolism , Humans , Kinetics , Macromolecular Substances , Mice , Protein Transport/immunology , Transfection , Tumor Cells, Cultured
SELECTION OF CITATIONS
SEARCH DETAIL
...